Dr Krishna Ella takes helm of Indian Vaccine Manufacturers Association as President
29 April 2024 | News
Dr Ella takes over the Presidency from Adar C Poonawala who held the post from 2019 to March 2024
The Indian Vaccine Manufacturers Association (IVMA) has announced Dr Krishna M Ella, a distinguished scientist and successful entrepreneur, as the association’s new President for a two-year period from April 2024-2026.
Dr Ella, Co-Founder, Executive Chairman of Bharat Biotech, acknowledged as the father of Genome Valley, and known for his pioneering work in biotechnology with his visionary leadership in the biotech industry, is set to steer the Association towards new horizons in vaccine development and production.
Dr Ella takes over the Presidency from Adar C Poonawala who held the post from 2019 to March 2024. For the current 2-year term, Mahima Datla, Managing Director of Biological E assumes the role of Vice President; T. Srinivas, CFO of Bharat Biotech, will be Treasurer and Dr Harshavardhan, will continue as Director General of IVMA.
His appointment comes at a critical time when the world is grappling with emerging infectious diseases and the need for preventative vaccine research and development, and access to safe and affordable vaccines, is more pressing than ever.
Under Dr Ella's leadership, the IVMA aims to fortify collaboration between vaccine manufacturers, researchers, and policymakers to accelerate the development of new vaccines and improve production processes.
IVMA's mission is to bring to the fore the Indian private-sector human vaccine manufacturer’s concerns related to the progress and profitability of the industry and in streamlining regulatory pathways and matters related to audits and inspections in consultations with the Central Drugs Standard and Control Organization.
